192 related articles for article (PubMed ID: 18644685)
21. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
Mancino MJ; McGaugh J; Chopra MP; Guise JB; Cargile C; Williams DK; Thostenson J; Kosten TR; Sanders N; Oliveto A
J Clin Psychopharmacol; 2014 Apr; 34(2):234-9. PubMed ID: 24525654
[TBL] [Abstract][Full Text] [Related]
22. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.
Schmitz JM; Stotts AL; Sayre SL; DeLaune KA; Grabowski J
Am J Addict; 2004; 13(4):333-41. PubMed ID: 15370932
[TBL] [Abstract][Full Text] [Related]
24. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
[TBL] [Abstract][Full Text] [Related]
25. Naltrexone for alcohol-dependent patients.
Ahmadi J; Babaeebeigi M; Maany I; Porter J; Mohagheghzadeh M; Ahmadi N; Dehbozorgi G
Ir J Med Sci; 2004; 173(1):34-7. PubMed ID: 15732235
[TBL] [Abstract][Full Text] [Related]
26. A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
Kamijima K; Kuboki T; Kumano H; Burt T; Cohen G; Arano I; Hamasaki T
Int Clin Psychopharmacol; 2005 Sep; 20(5):265-73. PubMed ID: 16096517
[TBL] [Abstract][Full Text] [Related]
27. Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.
Pettinati HM; Gastfriend DR; Dong Q; Kranzler HR; O'Malley SS
Alcohol Clin Exp Res; 2009 Feb; 33(2):350-6. PubMed ID: 19053979
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.
Mason BJ; Ritvo EC; Morgan RO; Salvato FR; Goldberg G; Welch B; Mantero-Atienza E
Alcohol Clin Exp Res; 1994 Oct; 18(5):1162-7. PubMed ID: 7847600
[TBL] [Abstract][Full Text] [Related]
29. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.
Heinälä P; Alho H; Kiianmaa K; Lönnqvist J; Kuoppasalmi K; Sinclair JD
J Clin Psychopharmacol; 2001 Jun; 21(3):287-92. PubMed ID: 11386491
[TBL] [Abstract][Full Text] [Related]
30. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism.
Anton RF; Moak DH; Latham PK; Waid LR; Malcolm RJ; Dias JK; Roberts JS
J Clin Psychopharmacol; 2001 Feb; 21(1):72-7. PubMed ID: 11199951
[TBL] [Abstract][Full Text] [Related]
31. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?
Dougherty DD; Loh R; Jenike MA; Keuthen NJ
J Clin Psychiatry; 2006 Jul; 67(7):1086-92. PubMed ID: 16889452
[TBL] [Abstract][Full Text] [Related]
32. Gabapentin combined with naltrexone for the treatment of alcohol dependence.
Anton RF; Myrick H; Wright TM; Latham PK; Baros AM; Waid LR; Randall PK
Am J Psychiatry; 2011 Jul; 168(7):709-17. PubMed ID: 21454917
[TBL] [Abstract][Full Text] [Related]
33. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
[TBL] [Abstract][Full Text] [Related]
34. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.
Weiss RD; O'malley SS; Hosking JD; Locastro JS; Swift R;
J Stud Alcohol Drugs; 2008 Nov; 69(6):878-84. PubMed ID: 18925346
[TBL] [Abstract][Full Text] [Related]
35. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
[TBL] [Abstract][Full Text] [Related]
36. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
Brown ES; Carmody TJ; Schmitz JM; Caetano R; Adinoff B; Swann AC; John Rush A
Alcohol Clin Exp Res; 2009 Nov; 33(11):1863-9. PubMed ID: 19673746
[TBL] [Abstract][Full Text] [Related]
38. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
Pettinati HM; Kampman KM; Lynch KG; Suh JJ; Dackis CA; Oslin DW; O'Brien CP
J Subst Abuse Treat; 2008 Jun; 34(4):378-90. PubMed ID: 17664051
[TBL] [Abstract][Full Text] [Related]
39. Treatments for alcohol dependence: rethinking the role of comorbidity and clinical subtypes.
Patkar AA; Li TK
Am J Psychiatry; 2010 Jun; 167(6):620-2. PubMed ID: 20516159
[No Abstract] [Full Text] [Related]
40. Sertraline treatment of co-occurring alcohol dependence and major depression.
Kranzler HR; Mueller T; Cornelius J; Pettinati HM; Moak D; Martin PR; Anthenelli R; Brower KJ; O'Malley S; Mason BJ; Hasin D; Keller M
J Clin Psychopharmacol; 2006 Feb; 26(1):13-20. PubMed ID: 16415699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
